{
 "companyname": "GTX INC /DE/",
 "symbol": "GTXI",
 "description": "Pharmaceutical Preparations",
 "quarters": [
  {
   "cik": "0001260990",
   "companyname": "GTX INC /DE/",
   "entityid": 591491,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "GTXI",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/9/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001104659-15-077270",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -899000,
   "changeincurrentliabilities": 1018000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": 0,
   "cashfromfinancingactivities": 0,
   "cashfrominvestingactivities": 2448000,
   "cashfromoperatingactivities": -4974000,
   "cfdepreciationamortization": 7000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": 2448000,
   "netchangeincash": -2526000,
   "totaladjustments": -39840000,
   "ebit": -5863000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": null,
   "incomebeforetaxes": 34866000,
   "interestexpense": null,
   "netincome": 34866000,
   "netincomeapplicabletocommon": 34866000,
   "researchdevelopmentexpense": 3824000,
   "totalrevenue": null,
   "sellinggeneraladministrativeexpenses": 2039000,
   "commonstock": 140000,
   "deferredcharges": null,
   "cashandcashequivalents": 11797000,
   "cashcashequivalentsandshortterminvestments": 34460000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": null,
   "othercurrentassets": null,
   "othercurrentliabilities": 30078000,
   "otherequity": null,
   "otherliabilities": 0,
   "preferredstock": null,
   "propertyplantequipmentnet": 8000,
   "retainedearnings": -510241000,
   "totalassets": 37778000,
   "totalcurrentassets": 36918000,
   "totalcurrentliabilities": 33466000,
   "totalliabilities": 33466000,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 4312000,
   "treasurystock": null
  },
  {
   "cik": "0001260990",
   "companyname": "GTX INC /DE/",
   "entityid": 591491,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "GTXI",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/10/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001104659-15-058302",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -1252000,
   "changeincurrentliabilities": 265000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -4000,
   "cashfromfinancingactivities": 0,
   "cashfrominvestingactivities": 5322000,
   "cashfromoperatingactivities": -5162000,
   "cfdepreciationamortization": 12000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": 5326000,
   "netchangeincash": 160000,
   "totaladjustments": 42790000,
   "ebit": -4961000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": null,
   "incomebeforetaxes": -47952000,
   "interestexpense": null,
   "netincome": -47952000,
   "netincomeapplicabletocommon": -47952000,
   "researchdevelopmentexpense": 2956000,
   "totalrevenue": null,
   "sellinggeneraladministrativeexpenses": 2005000,
   "commonstock": 140000,
   "deferredcharges": null,
   "cashandcashequivalents": 14323000,
   "cashcashequivalentsandshortterminvestments": 39434000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": null,
   "othercurrentassets": null,
   "othercurrentliabilities": 70798000,
   "otherequity": null,
   "otherliabilities": 0,
   "preferredstock": null,
   "propertyplantequipmentnet": 12000,
   "retainedearnings": -545107000,
   "totalassets": 41860000,
   "totalcurrentassets": 41290000,
   "totalcurrentliabilities": 73168000,
   "totalliabilities": 73168000,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": -31308000,
   "treasurystock": null
  },
  {
   "cik": "0001260990",
   "companyname": "GTX INC /DE/",
   "entityid": 591491,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "GTXI",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/11/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001104659-15-036849",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 157000,
   "changeincurrentliabilities": -287000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": 0,
   "cashfromfinancingactivities": 0,
   "cashfrominvestingactivities": 978000,
   "cashfromoperatingactivities": -4695000,
   "cfdepreciationamortization": 17000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": 978000,
   "netchangeincash": -3717000,
   "totaladjustments": -2311000,
   "ebit": -5059000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": null,
   "incomebeforetaxes": -2384000,
   "interestexpense": null,
   "netincome": -2384000,
   "netincomeapplicabletocommon": -2384000,
   "researchdevelopmentexpense": 2948000,
   "totalrevenue": null,
   "sellinggeneraladministrativeexpenses": 2111000,
   "commonstock": 140000,
   "deferredcharges": null,
   "cashandcashequivalents": 14163000,
   "cashcashequivalentsandshortterminvestments": 44600000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": null,
   "othercurrentassets": null,
   "othercurrentliabilities": 27782000,
   "otherequity": null,
   "otherliabilities": 20000,
   "preferredstock": null,
   "propertyplantequipmentnet": 16000,
   "retainedearnings": -497155000,
   "totalassets": 45782000,
   "totalcurrentassets": 45343000,
   "totalcurrentliabilities": 29867000,
   "totalliabilities": 29887000,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 15895000,
   "treasurystock": null
  }
 ]
}